Publications by authors named "Randy F Sweis"

26Publications

Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.

Front Immunol 2020 5;11:575258. Epub 2020 Nov 5.

Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, IL, United States.

View Article and Find Full Text PDF
November 2020

The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness.

Bladder Cancer 2020 Sep 21;6(3):225-235. Epub 2020 Sep 21.

Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago IL, USA.

View Article and Find Full Text PDF
September 2020

Morphological correlation of urinary bladder cancer molecular subtypes in radical cystectomies.

Hum Pathol 2020 Dec 26;106:54-61. Epub 2020 Sep 26.

Department of Pathology, University of Chicago, Chicago, IL, USA; Department of Surgery (Urology), University of Chicago, Chicago, IL, USA. Electronic address:

View Article and Find Full Text PDF
December 2020

Methods to assess anticancer immune responses in orthotopic bladder carcinomas.

Authors:
Randy F Sweis

Methods Enzymol 2020 24;635:127-137. Epub 2019 Oct 24.

Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, Chicago, IL, United States; Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL, United States; Committee on Immunology, University of Chicago, Chicago, IL, United States. Electronic address:

View Article and Find Full Text PDF
October 2019

Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer.

JAMA Oncol 2019 05;5(5):743

Section of Hematology/Oncology, Department of Medicine, Comprehensive Cancer Center, University of Chicago, Chicago, Illinois.

View Article and Find Full Text PDF
May 2019

Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy.

J Immunother Cancer 2019 03 11;7(1):66. Epub 2019 Mar 11.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.

View Article and Find Full Text PDF
March 2019

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.

Clin Cancer Res 2019 May 11;25(10):3074-3083. Epub 2019 Jan 11.

Department of Medicine, The University of Chicago, Chicago, Illinois.

View Article and Find Full Text PDF
May 2019

Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma.

Clin Genitourin Cancer 2019 Feb 12;17(1):e12-e18. Epub 2018 Oct 12.

Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL. Electronic address:

View Article and Find Full Text PDF
February 2019

Low clinical adoption of tumor genomic profiling: cause for concern?

J Med Econ 2018 Jul 15;21(7):721-723. Epub 2018 May 15.

a Department of Medicine, Section of Hematology/Oncology , Comprehensive Cancer Center, University of Chicago , IL , USA.

View Article and Find Full Text PDF
July 2018

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer.

J Immunother Cancer 2018 04 4;6(1):24. Epub 2018 Apr 4.

Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago Medicine, 5841 S. South Maryland Avenue, MC 2115, Chicago, IL, 60637, USA.

View Article and Find Full Text PDF
April 2018

Mechanistic and pharmacologic insights on immune checkpoint inhibitors.

Pharmacol Res 2017 Jun 18;120:1-9. Epub 2017 Mar 18.

Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL 60637, USA. Electronic address:

View Article and Find Full Text PDF
June 2017

Obviating the Need for Serial Biopsies Through Random Assignment.

J Clin Oncol 2017 01 31;35(2):260. Epub 2016 Oct 31.

Randy F. Sweis and Mark J. Ratain, University of Chicago, Chicago, IL.

View Article and Find Full Text PDF
January 2017

Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.

Urol Oncol 2016 12 9;34(12):556-565. Epub 2016 Nov 9.

Division of Hematology & Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article and Find Full Text PDF
December 2016

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma.

Clin Genitourin Cancer 2017 04 17;15(2):207-212. Epub 2016 Aug 17.

Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, Chicago, IL. Electronic address:

View Article and Find Full Text PDF
April 2017

Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.

Cancer Immunol Res 2016 07 17;4(7):563-8. Epub 2016 May 17.

Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. Department of Pathology, University of Chicago, Chicago, Illinois.

View Article and Find Full Text PDF
July 2016

Reply to T.A. Yap et al.

J Clin Oncol 2016 07 2;34(20):2432-3. Epub 2016 May 2.

University of Chicago, Chicago, IL

View Article and Find Full Text PDF
July 2016

Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.

Cureus 2016 Feb 26;8(2):e513. Epub 2016 Feb 26.

Medical Oncology and Therapeutics Research, City of Hope.

View Article and Find Full Text PDF
February 2016

Analysis of Impact of Post-Treatment Biopsies in Phase I Clinical Trials.

J Clin Oncol 2016 Feb 14;34(4):369-74. Epub 2015 Dec 14.

Randy F. Sweis and Michael W. Drazer, University of Chicago; Mark J. Ratain, University of Chicago Medical Center, Chicago, IL.

View Article and Find Full Text PDF
February 2016

Silver-catalyzed [2 + 2] cycloadditions of siloxy alkynes.

J Am Chem Soc 2004 Jun;126(24):7442-3

University of Chicago, Department of Chemistry, 5735 South Ellis Ave, Chicago, Illinois 60637, USA.

View Article and Find Full Text PDF
June 2004